logo

Sutro Biopharma Inc (STRO)



Trade STRO now with
  Date
  Headline
11/17/2021 7:09:50 AM Sutro Biopharma Appoints Heidi Hunter To Board
11/10/2021 7:14:59 AM Sutro Biopharma Q3 Loss Per Share $0.67 Vs Profit $0.45 Last Year
9/16/2021 7:05:24 AM Sutro Biopharma Names Nicole Chieffo VP Of Clinical Operations And Werner Rubas VP Of Preclinical Development
9/16/2021 7:00:00 AM Sutro Biopharma Announces Expansion of Leadership Team (Press Release)
8/18/2021 7:13:46 AM Sutro Biopharma Reports STRO-002 FDA Fast Track Designation For Patients With Advanced Ovarian Cancer
8/9/2021 7:38:15 AM Sutro Biopharma Q2 Net Loss $6.1 Mln Vs. Net Profit $29.9 Mln Last Year
5/7/2021 7:49:34 AM Sutro Biopharma Q1 Loss Per Share $0.66 Vs Loss Per Share $0.84 Last Year
4/15/2021 7:26:27 AM Sutro Biopharma Earns$15 Mln Milestone Payment From Cytokine Derivatives Collaboration With Merck
1/21/2021 7:11:50 AM Sutro Biopharma : First Patient Dosed In Dose-Expansion Study Of STRO-002 In Patients With Ovarian Cancer
12/8/2020 9:44:55 PM Sutro Biopharma Prices Public Offering Of 6 Mln Shares At $21.00/shr
12/7/2020 4:01:46 PM Sutro Biopharma Announces Proposed Public Offering Of 5 Mln Shares Of Common Stock
12/7/2020 10:09:57 AM Sutro Biopharma Presents Data From Ongoing Phase 1 Dose-Escalation Study For STRO-001